Compass Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANAB
|
AnaptysBio, Inc. | $21.16 | $640.07 M | -3.82 | 117 | $17.16 M |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.62 | $597.48 M | -6.84 | 51 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $12.23 | $1.29 B | -7.16 | 85 | $0 |
 ELVN
|
Enliven Therapeutics, Inc. | $25.43 | $984.95 M | -11.97 | 46 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $8.33 | $243.38 M | -1.59 | 133 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $0.67 | $124.06 M | -0.65 | 135 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $30.08 | $2.47 B | -23.59 | 136 | $0 |
 IDYA
|
IDEAYA Biosciences, Inc. | $26.61 | $2.88 B | -19 | 124 | $23.39 M |
 IVA
|
Inventiva S.A. | $2.51 | $185.39 M | -1.34 | 123 | $17.48 M |
 KRON
|
Kronos Bio, Inc. | $0.87 | $44.62 M | -0.37 | 58 | $6.29 M |
 KROS
|
Keros Therapeutics, Inc. | $53.82 | $1.76 B | -9.45 | 160 | $151,000 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.18 | $19.53 M | -0.27 | 88 | $1.56 M |
 MGTX
|
MeiraGTx Holdings plc | $5.92 | $306.74 M | -4.01 | 387 | $14.02 M |
 MLTX
|
MoonLake Immunotherapeutics | $52.02 | $2.62 B | -57.88 | 50 | $0 |
 NAMS
|
NewAmsterdam Pharma Company N.V. | $20.13 | $1.74 B | -7.15 | 62 | $12.76 M |
 NVCT
|
Nuvectis Pharma, Inc. | $4.91 | $116.38 M | -4.5 | 13 | $0 |
 PEPG
|
PepGen Inc. | $4.30 | $537.15 M | -5.11 | 76 | $0 |
 PRTC
|
PureTech Health plc | $21.78 | $809.08 M | -12.47 | 90 | $3.33 M |
 REPL
|
Replimune Group, Inc. | $11.07 | $485.18 M | -2.44 | 331 | $0 |
 TYRA
|
Tyra Biosciences, Inc. | $15.33 | $1.04 B | -11.7 | 49 | $0 |
 VIGL
|
Vigil Neuroscience, Inc. | $2.98 | $172.89 M | -2.17 | 64 | $0 |